2003
DOI: 10.1016/s0735-1097(03)82208-8
|View full text |Cite
|
Sign up to set email alerts
|

Endothelin-1 induces expression of functional CD40 on human vascular smooth muscle cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2009
2009
2012
2012

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…Importantly, endothelins also modulate trafficking, differentiation, and activation of tumor-associated immune cells (17)(18)(19)(20)(21)(22)(23)(24), possibly contributing to immune evasion and resistance to immunotherapy (25,26). ET-1 can induce expression of IL-6, MCP-1, and COX-2, key orchestrators of inflammation-mediated cancer cell invasiveness and metastasis via AP-1 and NF-κB (27,28), as well as MMP activity (9,22).…”
Section: Introductionmentioning
confidence: 99%
“…Importantly, endothelins also modulate trafficking, differentiation, and activation of tumor-associated immune cells (17)(18)(19)(20)(21)(22)(23)(24), possibly contributing to immune evasion and resistance to immunotherapy (25,26). ET-1 can induce expression of IL-6, MCP-1, and COX-2, key orchestrators of inflammation-mediated cancer cell invasiveness and metastasis via AP-1 and NF-κB (27,28), as well as MMP activity (9,22).…”
Section: Introductionmentioning
confidence: 99%
“…In addition to MMPs, CD40L was shown to stimulate SMCs to secrete cytokines such as MCP-1, IL-1␤, IL-6, and IL-8 (Lutgens and Daemen 2002;Mukundan et al 2004), contributing further to lesion progression and subsequent instability and rupture. It is worth noting at this point that an increased CD40 expression as well as activity has been reported in SMCs treated with the proatherogenic factors, Ang II and ET-1, via reactive oxygen specie (ROS) and NF-B pathways, respectively, emphasizing as such the important role of CD40L/CD40 dyad in atherosclerosis, as well as the synergy between various vasoactive factors and molecules in disease development (Browatzki et al 2007;Souza et al 2009). The atherogenic function of CD40L/CD40 dyad could even extend to the myofibroblast population in the atherosclerotic lesion.…”
Section: Cd40l Axis In Atherosclerosismentioning
confidence: 99%
“…For example, ET-1 promotes autocrine/paracrine interactions between fibroblasts and cancer cells in prostate and HNSCC cells ( Dawson et al, 2004 ) and modulates trafficking, differentiation, and activation of tumor-associated immune cells, possibly contributing to immune evasion and resistance to immunotherapy ( Kandalaft et al, 2009 ; Grimshaw et al, 2002 ; Buckanovich et al, 2008 ; Said et al, 2011 ). ET-1 can induce expression of IL-6, CCL-2, as well as MMP and COX-2 activity, key orchestrators of inflammation-mediated cancer cell invasiveness and metastasis via AP-1 and NF-κB ( Rosano et al, 2007a , 2001 , 2007b ; Sutcliffe et al, 2009 ; Grimshaw et al, 2002 , 2004 ; Said et al, 2011 ; Browatzki et al, 2007 ; Spinella et al, 2007 ). Recently, we reported that tumor ET-1 triggers inflammation in the lung soon after the cancer cells lodged at this site and thus sets up a vicious cycle wherein inflammatory cells would enhance and facilitate the process of metastatic colonization ( Said et al, 2011 ) ( Fig.…”
Section: Introductionmentioning
confidence: 99%